Amanda Marie Haney

Array ( [id] => 16712320 [patent_doc_number] => 20210079467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHODS OF DETERMINING LEVELS OF EXPOSURE TO RADIATION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/005548 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17444221 [patent_doc_number] => 20220064726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHOD FOR DETECTING POLYMERASE INCORPORATION OF NUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 17/418298 [patent_app_country] => US [patent_app_date] => 2020-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11382 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16452996 [patent_doc_number] => 20200362422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER [patent_app_type] => utility [patent_app_number] => 16/986667 [patent_app_country] => US [patent_app_date] => 2020-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16598470 [patent_doc_number] => 20210025001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => Methods for Detecting and Treating Idiopathic Pulmonary Fibrosis [patent_app_type] => utility [patent_app_number] => 16/938847 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18256584 [patent_doc_number] => 20230083623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => NUCLEIC ACID PROBES [patent_app_type] => utility [patent_app_number] => 17/904348 [patent_app_country] => US [patent_app_date] => 2020-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17761790 [patent_doc_number] => 20220235402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => METHOD OF SIGNAL ENCODING OF ANALYTES IN A SAMPLE [patent_app_type] => utility [patent_app_number] => 17/617183 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18003474 [patent_doc_number] => 20220362240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS [patent_app_type] => utility [patent_app_number] => 17/596711 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17157214 [patent_doc_number] => 20210318265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => POLYMERASE ATTACHMENT TO A CONDUCTIVE CHANNEL [patent_app_type] => utility [patent_app_number] => 17/256695 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10628 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17720826 [patent_doc_number] => 20220213546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => PROTOCOL FOR DETECTING INTERACTIONS WITHIN ONE OR MORE DNA MOLECULES WITHIN A CELL [patent_app_type] => utility [patent_app_number] => 17/612610 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16238679 [patent_doc_number] => 20200255913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => Novel Markers for Detecting Microsatellite Instability in Cancer and Determining Synthetic Lethality with Inhibition of the DNA Base Excision Repair Pathway [patent_app_type] => utility [patent_app_number] => 16/857490 [patent_app_country] => US [patent_app_date] => 2020-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17705034 [patent_doc_number] => 20220205040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => A METHOD TO PREDICT THE PREDISPOSITION TO AN EXERCISE PERFORMANCE TRAIT IN A HUMAN INDIVIDUAL [patent_app_type] => utility [patent_app_number] => 17/604536 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17688230 [patent_doc_number] => 20220195522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => MIR-151A-3P AS AN UNIVERSAL ENDOGENOUS CONTROL FOR EXOSOME CARGO NORMALIZATION [patent_app_type] => utility [patent_app_number] => 17/601657 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18267141 [patent_doc_number] => 20230088383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => METHOD FOR ASSESSING DIFFERENTIATION STATE OF CELLS, GELATIN NANOPARTICLES AND GELATIN NANOPARTICLE SET [patent_app_type] => utility [patent_app_number] => 17/910206 [patent_app_country] => US [patent_app_date] => 2020-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17910206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17611980 [patent_doc_number] => 20220154259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => METHOD FOR DETERMINING SIDE EFFECTS OF TRASTUZUMAB AND KIT FOR SAME [patent_app_type] => utility [patent_app_number] => 17/435766 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16157361 [patent_doc_number] => 20200216913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => COMPOSITIONS AND METHODS FOR CHARACTERIZING MARKER DNA FROM A SAMPLE [patent_app_type] => utility [patent_app_number] => 16/810385 [patent_app_country] => US [patent_app_date] => 2020-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18675675 [patent_doc_number] => 20230313295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => METHOD OF DETERMINING ENDOMETRIAL RECEPTIVITY AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/594567 [patent_app_country] => US [patent_app_date] => 2020-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16598468 [patent_doc_number] => 20210024999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => METHOD OF IDENTIFYING RISK FOR AUTISM [patent_app_type] => utility [patent_app_number] => 16/809496 [patent_app_country] => US [patent_app_date] => 2020-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9833 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16800451 [patent_doc_number] => 10995374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => Serotonin transporter gene and treatment of opioid-related disorders [patent_app_type] => utility [patent_app_number] => 16/807379 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37809 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17595823 [patent_doc_number] => 20220145397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => CANCER DIAGNOSIS AND PROGNOSIS [patent_app_type] => utility [patent_app_number] => 17/437381 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18299443 [patent_doc_number] => 20230109129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => DNA METHYLATION MARKER FOR PREDICTING RECURRENCE OF LIVER CANCER, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/434675 [patent_app_country] => US [patent_app_date] => 2020-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434675 [rel_patent_id] =>[rel_patent_doc_number] =>)